List of Excipients in API celecoxib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing celecoxib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | CROSCARMELLOSE SODIUM | |
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | GELATIN | |
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | LACTOSE MONOHYDRATE | |
| PFIZER LABORATORIES DIV PFIZER INC | CELEBREX | celecoxib | 0025-1515 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing celecoxib
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 | D&C RED NO. 28 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 | D&C YELLOW NO. 10 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 | FD&C BLUE NO. 1 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 | FD&C RED NO. 40 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for celecoxib
Excipient focus: ACESULFAME POTASSIUM
celecoxib drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
celecoxib drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| RxChange Co | celecoxib | 33358-902 |
| A-S Medication Solutions | celecoxib | 50090-6577 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
celecoxib drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| RxChange Co | celecoxib | 33358-902 |
| PD-Rx Pharmaceuticals Inc | celecoxib | 43063-825 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIUM GLYCYRRHIZATE
celecoxib drug variants containing AMMONIUM GLYCYRRHIZATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing AMMONIUM GLYCYRRHIZATE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: BANANA
celecoxib drug variants containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
celecoxib drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| RxChange Co | celecoxib | 33358-902 |
| A-S Medication Solutions | celecoxib | 50090-6577 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
celecoxib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
celecoxib drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
celecoxib drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| Macleods Pharmaceuticals Limited | celecoxib | 33342-155 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
celecoxib drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| Macleods Pharmaceuticals Limited | celecoxib | 33342-155 |
| RxChange Co | celecoxib | 33358-902 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
celecoxib drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| Mylan Institutional Inc | celecoxib | 51079-199 |
| Golden State Medical Supply Inc | celecoxib | 60429-459 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| NCS HealthCare of KY LLC dba Vangard Labs | celecoxib | 0615-8528 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
celecoxib drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| QPharma Inc | celecoxib | 42708-016 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 7
celecoxib drug variants containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| Qingdao BAHEAL Pharmaceutical Co Ltd | celecoxib | 70247-006 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
celecoxib drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| Unichem Pharmaceuticals (USA) Inc | celecoxib | 29300-157 |
| QPharma Inc | celecoxib | 42708-016 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| NCS HealthCare of KY LLC dba Vangard Labs | celecoxib | 0615-8528 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
celecoxib drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| RxChange Co | celecoxib | 33358-902 |
| EPIC PHARMA LLC | celecoxib | 42806-720 |
| PD-Rx Pharmaceuticals Inc | celecoxib | 43063-825 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
celecoxib drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY LLC dba Vangard Labs | celecoxib | 0615-8528 |
| Torrent Pharmaceuticals Limited | celecoxib | 13668-730 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
celecoxib drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Aphena Pharma Solutions - Tennessee LLC | celecoxib | 43353-257 |
| AvPAK | celecoxib | 50268-168 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
celecoxib drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | celecoxib | 13668-730 |
| Aphena Pharma Solutions - Tennessee LLC | celecoxib | 43353-257 |
| Chartwell RX LLC | celecoxib | 62135-021 |
| Yiling Pharmaceutical Inc | celecoxib | 69117-0020 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
celecoxib drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY LLC dba Vangard Labs | celecoxib | 0615-8528 |
| Macleods Pharmaceuticals Limited | celecoxib | 33342-155 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
celecoxib drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | celecoxib | 29300-157 |
| Amneal Pharmaceuticals LLC | celecoxib | 65162-817 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | celecoxib | 70247-006 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
celecoxib drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | celecoxib | 13668-307 |
| Alembic Pharmaceuticals Limited | celecoxib | 46708-267 |
| Aidarex Pharmaceuticals LLC | celecoxib | 53217-206 |
| Jubilant Cadista Pharmaceuticals Inc | celecoxib | 59746-561 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
celecoxib drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| RxChange Co | celecoxib | 33358-902 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY LLC dba Vangard Labs | celecoxib | 0615-8528 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
celecoxib drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-917 |
| Blenheim Pharmcal Inc | celecoxib | 10544-918 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
celecoxib drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
celecoxib drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLATE
celecoxib drug variants containing GLYCERYL MONOCAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing GLYCERYL MONOCAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
celecoxib drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | celecoxib | 33342-155 |
| PD-Rx Pharmaceuticals Inc | celecoxib | 43063-967 |
| Northwind Pharmaceuticals LLC | celecoxib | 51655-253 |
| Lake Erie Medical DBA Quality Care Products LLC | celecoxib | 55700-607 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
celecoxib drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| RxChange Co | celecoxib | 33358-902 |
| A-S Medication Solutions | celecoxib | 50090-6577 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
celecoxib drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| RxChange Co | celecoxib | 33358-902 |
| >Company | >Ingredient | >NDC |
Excipient focus: LAUROYL PEG-32 GLYCERIDES
celecoxib drug variants containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: LEVOMENTHOL
celecoxib drug variants containing LEVOMENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing LEVOMENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
celecoxib drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| QPharma Inc | celecoxib | 42708-016 |
| Unit Dose Services | celecoxib | 50436-3982 |
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
celecoxib drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| QPharma Inc | celecoxib | 42708-016 |
| Unit Dose Services | celecoxib | 50436-3982 |
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
celecoxib drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT
celecoxib drug variants containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
celecoxib drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 35 CASTOR OIL
celecoxib drug variants containing POLYOXYL 35 CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POLYOXYL 35 CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
celecoxib drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
celecoxib drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| NCS HealthCare of KY LLC dba Vangard Labs | celecoxib | 0615-8528 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-917 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
celecoxib drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| Blenheim Pharmacal Inc | celecoxib | 10544-953 |
| STAT RX USA LLC | celecoxib | 16590-045 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| NCS HealthCare of KY LLC dba Vangard Labs | celecoxib | 0615-8528 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K12
celecoxib drug variants containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Cardinal Health 107 LLC | celecoxib | 55154-7645 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
celecoxib drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| NCS HealthCare of KY LLC dba Vangard Labs | celecoxib | 0615-8528 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| Major Pharmaceuticals | celecoxib | 0904-6502 |
| Blenheim Pharmacal Inc | celecoxib | 10544-917 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
celecoxib drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | celecoxib | 10544-917 |
| Blenheim Pharmcal Inc | celecoxib | 10544-918 |
| Blenheim Pharmacal Inc | celecoxib | 10544-929 |
| Blenheim Pharmacal Inc | celecoxib | 10544-967 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYL GALLATE
celecoxib drug variants containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
celecoxib drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Blenheim Pharmacal Inc | celecoxib | 10544-917 |
| Blenheim Pharmcal Inc | celecoxib | 10544-918 |
| Blenheim Pharmacal Inc | celecoxib | 10544-929 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
celecoxib drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Blenheim Pharmacal Inc | celecoxib | 10544-917 |
| Blenheim Pharmcal Inc | celecoxib | 10544-918 |
| Blenheim Pharmacal Inc | celecoxib | 10544-929 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
celecoxib drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| EPIC PHARMA LLC | celecoxib | 42806-720 |
| Aphena Pharma Solutions - Tennessee LLC | celecoxib | 43353-257 |
| Mylan Institutional Inc | celecoxib | 51079-199 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
celecoxib drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | celecoxib | 33342-155 |
| PD-Rx Pharmaceuticals Inc | celecoxib | 43063-967 |
| ScieGen Pharmaceuticals Inc | celecoxib | 50228-156 |
| Northwind Pharmaceuticals LLC | celecoxib | 51655-253 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
celecoxib drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
celecoxib drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| QPharma Inc | celecoxib | 42708-016 |
| Unit Dose Services | celecoxib | 50436-3982 |
| Aurobindo Pharma Limited | celecoxib | 65862-907 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
celecoxib drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | celecoxib | 59385-055 |
| SCILEX PHARMACEUTICALS INC | celecoxib | 69557-333 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
celecoxib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | celecoxib | 65162-817 |
| Kowa Pharmaceuticals America Inc | celecoxib and tramadol hydrochloride | 66869-564 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
celecoxib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8338 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Blenheim Pharmacal Inc | celecoxib | 10544-917 |
| Blenheim Pharmcal Inc | celecoxib | 10544-918 |
| Blenheim Pharmacal Inc | celecoxib | 10544-929 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
celecoxib drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| REMEDYREPACK INC | celecoxib | 70518-4009 |
| Cadila Pharmaceuticals Limited | celecoxib | 71209-054 |
| Bryant Ranch Prepack | celecoxib | 72162-2421 |
| Modavar Pharmaceuticals LLC | celecoxib | 72241-022 |
| >Company | >Ingredient | >NDC |
celecoxib drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | celecoxib | 0025-1515 |
| Teva Pharmaceuticals USA Inc | celecoxib | 0093-7306 |
| Mylan Pharmaceuticals Inc | celecoxib | 0378-7165 |
| NCS HealthCare of KY Inc dba Vangard Labs | celecoxib | 0615-8297 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
